3 Execs Provide Parting Pearls On Taking A Company Public During The Pandemic

Source: Life Science Leader

In this executive virtual roundtable (EVR) segment, Tom Frohlich, CBO, Chinook Therapeutics; Marcio Souza, CEO of Praxis Precision Medicines; and David Perry, cofounder and chairman of Better Therapeutics, provide parting pearls gained from their varied experiences of taking a company public during a pandemic.